BRAF and central nervous system cancer: In this regard it is remarkable that these differences are more pronounced in individual cancer types with high frequencies of BRAF V600E (e.g. thyroid cancer, THCA) or IDH R132H (e.g. low-grade glioma, LGG; Fig 1E).